rs1545086

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181351.5(NCAM1):​c.916+1368C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.485 in 152,118 control chromosomes in the GnomAD database, including 18,909 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.48 ( 18909 hom., cov: 33)

Consequence

NCAM1
NM_181351.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.448

Publications

2 publications found
Variant links:
Genes affected
NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NCAM1NM_181351.5 linkc.916+1368C>T intron_variant Intron 7 of 19 ENST00000316851.12 NP_851996.2 P13591-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NCAM1ENST00000316851.12 linkc.916+1368C>T intron_variant Intron 7 of 19 5 NM_181351.5 ENSP00000318472.8 P13591-2

Frequencies

GnomAD3 genomes
AF:
0.484
AC:
73634
AN:
152000
Hom.:
18864
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.624
Gnomad AMI
AF:
0.283
Gnomad AMR
AF:
0.437
Gnomad ASJ
AF:
0.431
Gnomad EAS
AF:
0.729
Gnomad SAS
AF:
0.497
Gnomad FIN
AF:
0.330
Gnomad MID
AF:
0.449
Gnomad NFE
AF:
0.421
Gnomad OTH
AF:
0.462
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.485
AC:
73734
AN:
152118
Hom.:
18909
Cov.:
33
AF XY:
0.482
AC XY:
35833
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.624
AC:
25904
AN:
41498
American (AMR)
AF:
0.437
AC:
6680
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.431
AC:
1495
AN:
3468
East Asian (EAS)
AF:
0.728
AC:
3775
AN:
5182
South Asian (SAS)
AF:
0.495
AC:
2384
AN:
4812
European-Finnish (FIN)
AF:
0.330
AC:
3492
AN:
10566
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.421
AC:
28623
AN:
67984
Other (OTH)
AF:
0.469
AC:
991
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1944
3888
5831
7775
9719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.454
Hom.:
2074
Bravo
AF:
0.498
Asia WGS
AF:
0.630
AC:
2192
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.67
DANN
Benign
0.64
PhyloP100
-0.45
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1545086; hg19: chr11-113080092; API